Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Cuthbertson

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Lancet (London, England)|March 29, 2001
Clinical picture: occult ectopic ACTH syndromeD J Cuthbertson, S Vinjamuri, D Bowen-Jones
Diabetic Medicine : a Journal of the British Diabetic Association|February 20, 2007
Hepatic glycogenosis: abnormal liver function tests in Type 1 diabetesD J Cuthbertson, G Brennan, S Walsh, et al.
Clinical Therapeutics|August 27, 2021
Emerging and Established Therapeutic Approaches for Nonalcoholic Fatty Liver DiseaseEmily Brown, T Hydes, A Hamid, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|January 13, 2015
Impact of bariatric surgery on physical functioning in obese adultsT Steele, D J Cuthbertson, J P H Wilding
Diabetes, Obesity & Metabolism|September 26, 2015
Energy balance and metabolic changes with sodium-glucose co-transporter 2 inhibitionS P Rajeev, D J Cuthbertson, J P H Wilding
The Journal of Frailty & Aging|January 11, 2023
Dynapenic Abdominal Obesity as a Risk Factor for FallsL Dowling, E McCloskey, D J Cuthbertson, et al.
International Journal of Clinical Practice|June 30, 2006
Optimisation of thyroid hormone replacement using an automated thyroid registerD J Cuthbertson, R Flynn, R T Jung, et al.
Clinical Therapeutics|August 17, 2021
Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research ApplicationsT Hydes, E Brown, A Hamid, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 11, 2012
Effects of chronic treatment with metformin on dipeptidyl peptidase-4 activity, glucagon-like peptide 1 and ghrelin in obese patients with Type 2 diabetes mellitusS K Thondam, A Cross, D J Cuthbertson, et al.
Journal of Human Hypertension|March 10, 2017
<sup>11</sup>C-metomidate PET-CT scanning can identify aldosterone-producing adenomas after unsuccessful lateralisation with CT/MRI and adrenal venous samplingJ Ouyang, R Hardy, M Brown, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Lancet (London, England)|March 29, 2001
Clinical picture: occult ectopic ACTH syndromeD J Cuthbertson, S Vinjamuri, D Bowen-Jones
Diabetic Medicine : a Journal of the British Diabetic Association|February 20, 2007
Hepatic glycogenosis: abnormal liver function tests in Type 1 diabetesD J Cuthbertson, G Brennan, S Walsh, et al.
Clinical Therapeutics|August 27, 2021
Emerging and Established Therapeutic Approaches for Nonalcoholic Fatty Liver DiseaseEmily Brown, T Hydes, A Hamid, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|January 13, 2015
Impact of bariatric surgery on physical functioning in obese adultsT Steele, D J Cuthbertson, J P H Wilding
Diabetes, Obesity & Metabolism|September 26, 2015
Energy balance and metabolic changes with sodium-glucose co-transporter 2 inhibitionS P Rajeev, D J Cuthbertson, J P H Wilding
The Journal of Frailty & Aging|January 11, 2023
Dynapenic Abdominal Obesity as a Risk Factor for FallsL Dowling, E McCloskey, D J Cuthbertson, et al.
International Journal of Clinical Practice|June 30, 2006
Optimisation of thyroid hormone replacement using an automated thyroid registerD J Cuthbertson, R Flynn, R T Jung, et al.
Clinical Therapeutics|August 17, 2021
Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research ApplicationsT Hydes, E Brown, A Hamid, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 11, 2012
Effects of chronic treatment with metformin on dipeptidyl peptidase-4 activity, glucagon-like peptide 1 and ghrelin in obese patients with Type 2 diabetes mellitusS K Thondam, A Cross, D J Cuthbertson, et al.
Journal of Human Hypertension|March 10, 2017
<sup>11</sup>C-metomidate PET-CT scanning can identify aldosterone-producing adenomas after unsuccessful lateralisation with CT/MRI and adrenal venous samplingJ Ouyang, R Hardy, M Brown, et al.
Pageof 4